Delayed
London S.E.
06:11:48 10/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
20.32
GBX
|
-2.05%
|
|
+4.23%
|
-20.29%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
14.35
|
54.3
|
24.94
|
34.77
|
38.85
|
39.81
|
39.81
|
-
|
Enterprise Value (EV)
1 |
30.6
|
62.04
|
24.94
|
37.17
|
39.54
|
47.99
|
39.97
|
42.45
|
P/E ratio
|
-16.3
x
|
116
x
|
-
|
4.67
x
|
6.3
x
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.78
x
|
2.29
x
|
1.19
x
|
1.1
x
|
1.14
x
|
1.22
x
|
0.98
x
|
0.91
x
|
EV / Revenue
|
1.66
x
|
2.62
x
|
1.19
x
|
1.18
x
|
1.16
x
|
1.2
x
|
0.98
x
|
0.97
x
|
EV / EBITDA
|
15.1
x
|
17.3
x
|
7.48
x
|
6.62
x
|
4.29
x
|
5.56
x
|
5.87
x
|
5.96
x
|
EV / FCF
|
2,68,80,756
x
|
4,57,34,436
x
|
-
|
71,42,208
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
0%
|
-
|
-
|
-
|
-
|
Price to Book
|
3.16
x
|
-
|
-
|
1.43
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,27,569
|
1,91,858
|
1,91,858
|
1,91,858
|
1,91,858
|
1,91,858
|
1,91,858
|
-
|
Reference price
2 |
0.1125
|
0.2830
|
0.1300
|
0.1812
|
0.2025
|
0.2075
|
0.2075
|
0.2075
|
Announcement Date
|
01/05/19
|
27/05/20
|
25/05/21
|
09/05/22
|
25/04/23
|
02/05/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
18.39
|
23.69
|
20.97
|
31.57
|
34.02
|
40.07
|
40.6
|
43.56
|
EBITDA
1 |
2.028
|
3.582
|
3.334
|
5.615
|
9.21
|
8.633
|
6.806
|
7.126
|
EBIT
|
0.8182
|
2.276
|
2.067
|
4.215
|
7.745
|
-
|
-
|
-
|
Operating Margin
|
4.45%
|
9.61%
|
9.85%
|
13.35%
|
22.77%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-1.055
|
0.4475
|
-
|
4.141
|
8.055
|
-
|
-
|
-
|
Net income
|
-0.8775
|
0.4475
|
-
|
7.429
|
6.316
|
-
|
-
|
-
|
Net margin
|
-4.77%
|
1.89%
|
-
|
23.53%
|
18.57%
|
-
|
-
|
-
|
EPS
|
-0.006910
|
0.002430
|
-
|
0.0388
|
0.0321
|
-
|
-
|
-
|
Free Cash Flow
|
1.138
|
1.356
|
-
|
5.205
|
-
|
-
|
-
|
-
|
FCF margin
|
6.19%
|
5.73%
|
-
|
16.49%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
56.12%
|
37.87%
|
-
|
92.69%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
303.12%
|
-
|
70.06%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/05/19
|
27/05/20
|
25/05/21
|
09/05/22
|
25/04/23
|
02/05/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
16.2
|
7.74
|
-
|
2.4
|
0.69
|
-
|
0.16
|
2.64
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
0.93
|
-
|
-
|
Leverage (Debt/EBITDA)
|
8.011
x
|
2.161
x
|
-
|
0.4271
x
|
0.0751
x
|
-
|
0.0235
x
|
0.3706
x
|
Free Cash Flow
|
1.14
|
1.36
|
-
|
5.2
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-25.7%
|
1.27%
|
-
|
36.3%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
0.0400
|
-
|
-
|
0.1300
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.69
|
1.39
|
-
|
1.21
|
2.49
|
4.99
|
6.41
|
7.21
|
Capex / Sales
|
3.77%
|
5.86%
|
-
|
3.82%
|
7.32%
|
12.45%
|
15.78%
|
16.54%
|
Announcement Date
|
01/05/19
|
27/05/20
|
25/05/21
|
09/05/22
|
25/04/23
|
02/05/24
|
-
|
-
|
Last Close Price
0.2075
GBP Average target price
0.35
GBP Spread / Average Target +68.67% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.29% | 49.82M | | +17.76% | 66.7B | | +1.94% | 48.83B | | +16.42% | 41.51B | | +18.68% | 26.72B | | +12.85% | 19.58B | | -21.87% | 16.02B | | -7.57% | 15.7B | | +1.87% | 15.58B | | -19.79% | 13.8B |
Other Specialty Chemicals
|